when did semaglutide get approved FDA-Approved Oral Pills for Weight Loss The FDA's Decision to Ban

GLP-1 Users for Weight Management represent a 31.8% share, driven by the widespread adoption of GLP-1 receptor agonists specifically for obesity and weight management, along with the corresponding demand for protein, hydration, and micronutrient support to mitigate side effects and maintain nutritional balance

Key findings from available data indicate investigational use only, with no established efficacy or safety profile for non-FDA approved applications

The phase 2 dose-ranging trial (NCT02970942) included 320 individuals with histologically proven MASH and hepatic fibrosis F1-F3, randomizing them 3:3:3:1:1:1 to daily subcutaneous administration of semaglutide 0.1, 0.2, or 0.4 mg, or placebo for 72 weeks [18]

Take the first step toward recovery with a cutting-edge treatment that harnesses your bodys natural healing power

W., Madsen, C., Gram, L